More than 11% of American adults live with diabetes, and Miami-Dade County has some of the highest rates of the disease in Florida. The good news is that with the right primary care team, diabetes is a highly manageable condition. Here is what modern diabetes management actually looks like.
Diabetes in Miami-Dade: Understanding the Scope
Diabetes affects more than 37 million Americans — approximately 11.3% of the population — and an additional 96 million adults have prediabetes, many of them unaware of their status. In Florida, and particularly in Miami-Dade County, rates of type 2 diabetes are elevated, driven by a combination of genetic predisposition in Hispanic populations, dietary patterns, and historically limited access to consistent primary care.
The critical insight from decades of research is this: diabetes is not a sentence. It is a manageable chronic condition, and your primary care physician is your most important partner in managing it. At Viva Medical Center in Doral, FL, we take a comprehensive, evidence-based approach to diabetes management that empowers patients to live full, healthy lives.
What Are the Current A1C Targets?
The American Diabetes Association (ADA) 2025 Standards of Care recommend an A1C goal of less than 7% for most non-pregnant adults with diabetes, corresponding to an estimated average blood glucose of approximately 154 mg/dL. However, the ADA strongly emphasizes individualization — targets may be less aggressive (less than 8%) for older adults, those with limited life expectancy, or patients with frequent hypoglycemia, and more aggressive (less than 6.5%) for younger patients with newly diagnosed type 2 diabetes and no significant comorbidities.
Your preprandial (before meals) blood glucose target is generally 80–130 mg/dL, and your postprandial (after meals) target is less than 180 mg/dL. These numbers are not abstract benchmarks — they are the difference between controlled disease and progressive damage to your kidneys, eyes, nerves, and cardiovascular system.
The Role of GLP-1 Medications in Modern Diabetes Care
One of the most significant advances in diabetes treatment over the past decade has been the rise of GLP-1 receptor agonists — medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The 2024 and 2025 ADA guidelines now strongly recommend GLP-1 receptor agonists for patients with type 2 diabetes and established cardiovascular disease or high cardiovascular risk, regardless of whether metformin is already in use and regardless of baseline A1C levels.
This recommendation reflects robust clinical evidence. GLP-1 medications lower A1C by 1–2% or more, promote weight loss, reduce the risk of major cardiovascular events (MACE) with a hazard ratio of approximately 0.80, and provide kidney-protective effects. They also carry a significantly lower risk of hypoglycemia compared to insulin or sulfonylureas. When a GLP-1 receptor agonist is added to a diabetes regimen, patients can expect a 1% to greater than 2% reduction in A1C.
A Comprehensive Diabetes Management Plan at Viva Medical Center
Effective diabetes management near me goes far beyond prescribing a medication. At Viva Medical Center, our approach includes several essential components working together.
Regular monitoring: A1C is checked every 3–6 months depending on disease control. We also monitor fasting glucose, postprandial glucose where appropriate, kidney function (eGFR, urine albumin-to-creatinine ratio), and lipid panels. Annual dilated eye exams, foot exams, and dental care referrals are coordinated as part of your care plan.
Medication management: We use a shared decision-making approach to select medications based on your cardiovascular risk, kidney function, weight goals, insurance coverage, and personal preferences. Metformin remains a first-line option for many patients, and we integrate GLP-1 receptor agonists, SGLT-2 inhibitors, and other agents according to current ADA guidelines.
Nutrition counseling: No diabetes management plan is complete without dietary guidance. Our team provides practical, culturally appropriate nutrition education — including guidance adapted for traditional Latin American diets — without rigid restriction that leads to non-adherence.
Physical activity support: The ADA recommends at least 150 minutes of moderate-intensity aerobic activity per week for adults with diabetes, combined with resistance training at least twice weekly. We help patients build realistic activity plans within their physical abilities and lifestyle.
Prediabetes: The Window of Opportunity
If your A1C is between 5.7% and 6.4%, or your fasting glucose is between 100–125 mg/dL, you have prediabetes. This is a critical window — research from the Diabetes Prevention Program demonstrated that intensive lifestyle intervention reduces progression from prediabetes to type 2 diabetes by 58% over three years. In the same study, metformin reduced progression by 31%.
At Viva Medical Center, we screen all at-risk patients for prediabetes and offer structured intervention programs to help you reverse course before diabetes develops.
Managing Diabetes Alongside Other Conditions
Diabetes rarely travels alone. Most patients with type 2 diabetes also manage hypertension, dyslipidemia, obesity, and sometimes kidney disease or neuropathy. Our primary care team is equipped to manage all of these conditions in a coordinated way — reducing the burden of navigating multiple specialists while ensuring nothing falls through the cracks.
Take Control at Viva Medical Center in Doral, FL
If you are searching for diabetes management near me or a primary care physician near me who takes diabetes seriously, Viva Medical Center is here. Our bilingual, board-certified team in Doral, FL offers comprehensive diabetes care — from diagnosis and medication management to nutrition support and long-term monitoring. Call us today or book your appointment online. Hablamos español.
Interested in learning more? Explore our Primary Care services at Viva Medical Center in Doral, FL.